acut
febril
respiratori
ill
fri
lead
respiratori
failur
common
reason
admiss
icu
viral
pneumonia
constitut
portion
case
often
viral
etiolog
goe
undiagnos
emerg
viral
infecti
diseas
sever
acut
respiratori
syndrom
avian
influenza
present
acut
fri
progress
respiratori
failur
ard
therefor
earli
recognit
viral
caus
acut
fri
lead
ard
becom
import
protect
healthcar
worker
hcw
lessen
spread
patient
notif
public
health
offici
patient
often
longer
cours
viral
shed
undergo
higherrisk
procedur
may
potenti
gener
aerosol
intub
bronchoscopi
bagvalv
mask
ventil
noninvas
posit
pressur
ventil
medic
nebul
illustr
import
earli
detect
isol
small
number
viral
agent
lead
acut
fri
respiratori
failur
ard
season
influenza
avian
influenza
coronaviru
associ
sever
ard
respiratori
syncyti
viru
adenoviru
varicella
human
metapneumoviru
hantaviru
systemat
approach
earli
isol
test
agent
public
health
involv
becom
import
deal
acut
fri
ultim
approach
lead
improv
hcw
protect
reduct
transmiss
patient
prevent
transmiss
commun
abbrevi
cpr
cardiopulmonari
resuscit
fri
febril
respiratori
ill
hcw
healthcar
worker
hmpv
human
metapneumoviru
hp
hantaviru
pulmonari
syndrom
ili
influenzalik
ill
pcr
polymeras
chain
reaction
ppe
person
protect
equip
rsv
respiratori
syncyti
viru
rt
revers
transcriptas
sar
sever
acut
respiratori
syndrom
uri
upper
respiratori
tract
infect
vzv
varicella
zoster
viru
f
ebril
respiratori
ill
fri
lead
respiratori
failur
common
reason
admiss
commun
icu
commun
caus
pneumonia
constitut
case
case
communityacquir
pneumonia
may
progress
ard
concern
mani
emerg
infecti
diseas
avian
influenza
sever
acut
respiratori
syndrom
sar
present
fri
acut
respiratori
failur
ard
earli
recognit
fri
respiratori
failur
import
order
implement
earli
infectioncontrol
strategi
reduc
transmiss
healthcar
worker
hcw
patient
well
provid
detect
pathogen
public
health
import
icu
patient
fri
respiratori
failur
may
infecti
earli
phase
diseas
patient
frequent
requir
aerosolgener
procedur
facilit
transmiss
icu
earli
recognit
fri
becom
import
reduc
likelihood
transmiss
within
icu
hcw
visitor
patient
ultim
commun
therefor
approach
patient
fri
respiratori
failur
need
evolv
includ
public
health
perspect
addit
focu
individu
diagnosi
treatment
standard
approach
earli
recognit
isol
fri
follow
earli
aggress
diagnost
test
treatment
public
health
involv
necessari
protect
hcw
patient
commun
known
unknown
emerg
infecti
diseas
unfortun
exact
etiolog
fri
respiratori
failur
lead
ard
unknown
time
admiss
icu
half
fri
respiratori
failur
one
bacteria
agent
communityacquir
pneumonia
larg
identifi
shortli
isol
admiss
icu
routin
cultur
test
approxim
fri
patient
admit
icu
viral
origin
prospect
studi
sinc
prospect
cohort
studi
perform
small
number
viral
etiolog
document
literatur
therefor
earli
cours
fri
care
patient
focu
appropri
isol
follow
diagnost
test
one
routin
bacteri
agent
fri
identifi
diagnost
focu
shift
possibl
viral
caus
shift
also
involv
public
health
commun
particularli
known
viral
pathogen
public
health
concern
suspect
viral
test
unsuccess
therefor
familiar
common
viral
pathogen
caus
fri
respiratori
failur
ard
normal
mildli
immunocompromis
bone
marrow
transplant
hiv
host
along
epidemiolog
clinic
featur
treatment
outcom
becom
import
order
facilit
rapid
isol
test
diagnosi
public
health
involv
acut
respiratori
ill
caus
either
influenza
b
often
season
outbreak
influenza
three
major
hemagglutinin
subtyp
two
neuroaminidas
subtyp
describ
human
frequent
antigen
drift
glycoprotien
influenza
b
less
propens
antigen
shift
genet
drift
hemagglutinin
describ
allow
season
variabl
influenza
b
circul
yearli
influenza
begin
abruptli
influenza
b
case
predomin
later
part
season
howev
region
differ
exist
b
strain
found
europ
asia
influenza
b
common
longterm
care
facil
school
institut
case
influenza
selflimit
infect
nonspecif
symptom
fever
headach
myalgia
malais
influenzalik
ill
ili
tradit
influenza
b
mild
selflimit
cours
differ
determin
clinic
ground
alon
requir
laboratori
confirm
howev
smaller
number
individu
influenza
b
particularli
higherrisk
individu
tabl
like
primari
pneumonia
respiratori
symptom
persist
progress
minor
case
ard
develop
occur
individu
higher
risk
chronic
pulmonari
disord
healthi
individu
progress
describ
well
major
death
season
outbreak
occur
primari
pneumonia
secondari
bacteri
pneumonia
season
outbreak
diagnosi
made
clinic
good
reliabl
combin
fever
cough
posit
predict
valu
definit
diagnosi
made
viral
detect
nasalpharyng
aspir
swab
lower
respiratori
tract
sampl
patient
appropri
clinic
symptom
subtyp
done
polymeras
chain
reaction
pcr
public
health
laboratori
tabl
rapid
influenza
viral
diagnost
test
use
immunofluoresc
enzym
immunoassay
provid
rapid
reliabl
test
detect
influenza
b
strain
howev
viral
shed
peak
h
ill
declin
thereaft
thu
pcr
test
lower
respiratori
tract
sampl
fri
ard
may
benefici
addit
subtyp
suspect
case
influenzarel
fri
ard
requir
viru
isol
sent
public
health
laboratori
treatment
influenza
undertaken
agent
two
antivir
class
adamantan
neuroaminidas
inhibitor
due
widespread
resist
adamantan
use
drug
reserv
case
outbreak
known
suscept
tabl
studi
neuraminidas
inhibitor
show
reduct
symptom
time
viral
shed
best
effect
seen
drug
start
within
h
symptom
onset
treatment
neuroaminidas
inhibitor
h
may
provid
addit
benefit
fulli
studi
viral
resist
neuroaminidas
inhibitor
low
within
commun
influenza
suspect
winter
epidem
season
travel
endem
area
occur
transmiss
primarili
droplet
contact
respiratori
secret
patient
suspect
influenza
infect
place
droplet
isol
hcw
wear
surgic
mask
face
shield
eye
protect
gown
glove
appropri
person
protect
equip
ppe
novel
strain
detect
laboratori
test
hcw
wear
mask
patient
place
airborn
isol
instead
mechan
transmiss
understood
base
sar
experi
higherrisk
procedur
gener
aerosol
tabl
may
requir
use
mask
power
airpurifi
respir
avian
influenza
avian
influenza
infect
human
increas
incid
past
decad
infect
caus
avian
subtyp
influenza
usual
patient
report
contact
sick
dead
poultri
although
humantohuman
case
transmiss
occur
subtyp
present
conjunct
highli
pathogen
subtyp
present
sever
primari
pneumonia
respiratori
failur
ard
tabl
respiratori
failur
multiorgan
damag
seen
case
total
mortal
rate
admit
icu
respiratori
failur
mortal
rate
observ
mortal
repres
clinic
patient
sought
health
care
populationbas
questionnair
survey
suggest
milder
even
subclin
infect
may
exist
thu
like
significantli
lower
case
fatal
rate
diagnosi
revers
transcriptas
rt
pcr
viral
isol
requir
biosafeti
level
laboratori
patient
appropri
clinic
symptom
epidemiolog
risk
factor
alway
involv
public
health
offici
treatment
support
addit
neuroaminidas
inhibitor
largest
treatment
experi
oseltamivir
reduct
viru
nasal
wash
demonstr
resist
demonstr
larg
due
point
mutat
chang
histidin
tyrosin
within
neuraminidas
receptor
vitro
test
strain
shown
resist
overcom
higher
dose
oseltamivir
larger
studi
perform
addit
resist
confer
zanamivir
case
initi
detect
epidemiolog
link
contact
sick
dead
bird
transmiss
like
droplet
airborn
transmiss
propos
offici
prompt
higher
level
protect
ingest
undercook
poultri
swim
infect
waterfowl
also
suspect
rout
human
infect
isol
case
avian
influenza
human
manag
differ
pandem
influenza
suspect
patient
initi
place
airborn
isol
hcw
wear
mask
appropri
level
power
airpurifi
respir
protect
isol
case
humantohuman
transmiss
probabl
occur
among
hcw
case
appropri
ppe
use
aerosolgener
procedur
reduc
possibl
tabl
final
suspect
case
avian
influenza
prompt
urgent
notif
local
public
health
offici
infect
verifi
commun
measur
reduc
spread
institut
sar
caus
novel
coronaviru
first
detect
thousand
case
occur
worldwid
initi
epidem
epidem
abat
new
case
report
sinc
clinic
present
character
fever
chill
rigor
malais
nausea
short
breath
tabl
symptom
occur
averag
day
contact
pneumonia
appear
develop
approxim
day
onset
fever
patient
hypoxemia
approxim
case
went
sever
lung
injuri
ard
requir
mechan
ventil
develop
ard
onset
fever
bimod
peak
day
day
global
fatal
rate
death
patient
year
old
death
report
children
diagnosi
includ
ili
sever
pneumonia
presenc
epidem
laboratori
exposur
viral
detect
rtpcr
respiratori
sampl
tabl
serum
immunofluoresc
assay
may
detect
case
long
onset
public
health
laboratori
perform
test
center
diseas
control
prevent
treatment
larg
support
steroid
use
case
develop
ard
initi
case
difficult
identifi
result
extens
spread
hcw
spread
droplet
transmiss
although
mani
case
suggest
airborn
contact
rout
also
occur
outbreak
analysi
rule
oralfec
spread
well
spread
hcw
wore
appropri
ppe
suggest
airborn
spread
addit
spread
aerosolgener
procedur
cardiopulmonari
resuscit
cpr
intub
medic
nebul
noninvas
posit
pressur
ventil
experi
sar
particularli
among
hcw
support
approach
care
requir
earli
isol
enhanc
ppe
engag
certain
higherrisk
procedur
tabl
epidem
wane
within
month
detect
base
clinic
ground
would
requir
high
level
suspicion
either
context
known
laboratori
exposur
new
confirm
sar
outbreak
epidemiolog
risk
therefor
consider
sar
anoth
potenti
viru
promptli
report
hospit
infect
control
public
health
offici
respiratori
syncyti
viru
rsv
caus
acut
respiratori
tract
infect
age
common
caus
lower
respiratori
tract
infect
children
year
age
adult
rsv
infect
develop
elderli
adult
even
higher
highrisk
group
infect
follow
pattern
similar
influenza
epidem
occur
winter
month
adult
infect
manifest
predomin
upper
respiratori
tract
symptom
patient
lower
respiratori
tract
infect
includ
bronchiol
pneumonia
bronchospasm
acut
respiratori
failur
ard
tabl
lower
respiratori
tract
diseas
usual
occur
primari
infect
children
occur
recurr
infect
adulthood
elderli
immunocompromis
particularli
bone
marrow
transplant
patient
highest
risk
respiratori
failur
diagnosi
clinic
find
epidem
period
rapid
antigen
assay
viral
isol
rtpcr
detect
treatment
bronchospasm
includ
bronchodil
steroid
ribavirin
sever
highrisk
case
howev
one
recent
random
control
trial
evalu
children
month
age
moderatetosever
bronchiol
major
case
caus
rsv
result
show
singl
dose
dexamethason
alter
admiss
rate
length
stay
respiratori
statu
overal
patient
infect
admit
icu
mortal
rate
surprisingli
high
case
elderli
infect
rare
occur
outsid
winter
month
unless
travel
epidem
area
occur
spread
larg
contact
droplet
transmiss
contact
transmiss
play
signific
role
compar
respiratori
virus
therefor
hand
wash
greatli
reduc
spread
rsv
addit
droplet
isol
appropri
ppe
viral
shed
last
day
averag
higherrisk
individu
icu
immunocompromis
solidorgan
transplant
elderli
may
shed
longer
isol
continu
h
cessat
fever
adenoviru
one
common
caus
upper
respiratori
tract
infect
uri
adult
children
howev
sever
lower
respiratori
tract
diseas
describ
healthi
atrisk
individu
particularli
militari
institut
set
pneumonia
ard
develop
minor
individu
usual
associ
conjunct
extrapulmonari
manifest
gi
diseas
hepat
mening
hemmorhag
cystiti
extrapulmonari
complic
along
ard
frequent
transplant
recipi
pneumonia
ard
appear
common
subtyp
e
type
subgroup
b
type
serogroup
document
longterm
health
facil
mental
health
facil
diagnosi
made
antigen
assay
pcr
viral
cultur
prefer
sever
pneumonia
institut
outbreak
serotyp
desir
tabl
treatment
larg
support
although
cidofovir
gancyclovir
activ
vitro
past
vaccin
militari
recruit
serotyp
constitut
case
pneumonia
howev
sole
produc
vaccin
stop
product
militari
longer
routin
vaccin
recruit
contact
infect
fomit
play
larg
role
transmiss
adenoviru
remain
viabl
environment
surfac
long
period
time
amount
droplet
transmiss
also
occur
viru
long
period
shed
transplant
patient
therefor
aggress
decontamin
environment
surfac
along
contact
droplet
precaut
indic
public
health
offici
contact
case
involv
institut
set
serotyp
desir
varicellazost
viru
vzv
infect
caus
acut
recurr
febril
ill
follow
malais
pharyng
vesicular
rash
primari
diseas
occur
throughout
year
usual
benign
immunocompet
individu
recurr
diseas
seen
immuncompromis
adult
pneumonia
develop
primari
infect
occur
rare
children
progress
respiratori
failur
ard
pneumonia
frequent
seriou
complic
vzv
infect
adult
incid
approxim
primari
vzv
risk
factor
pneumonia
respiratori
failur
ard
includ
pregnanc
smoke
immunosuppress
pneumonia
respiratori
failur
develop
slowli
usual
day
onset
rash
signal
tachypnea
hypoxia
addit
complic
includ
enceph
hepat
secondari
skin
softtissu
infect
overal
mortal
rate
vzv
pneumonia
remain
high
patient
requir
icu
admiss
mechan
ventil
mortal
rate
approach
clinic
examin
yield
diagnosi
mani
case
vesicular
rash
accompani
pulmonari
diseas
confirm
diagnosi
done
viral
isol
cultur
immunosorb
assay
patholog
find
biopsi
treatment
includ
acyclovir
corticosteroid
shown
lessen
hospit
icu
stay
alter
mortal
rate
routin
use
vaccin
alter
typic
present
children
breakthrough
infect
singl
dose
infect
usual
less
sever
produc
lesion
averag
rare
present
pneumonia
immun
appear
wane
year
recent
recommend
call
second
booster
dose
vaccin
within
year
first
spread
direct
contact
skin
lesion
case
primari
infect
pneumonia
droplet
transmiss
also
import
rout
infect
period
long
onset
fever
prior
rash
lesion
crust
pneumonia
improv
therefor
hcw
famili
member
immun
prior
infect
must
avoid
contact
contact
infect
patient
must
occur
protect
equip
includ
gown
glove
mask
eye
protect
must
worn
vaccin
nonimmun
hcw
also
perform
reduc
risk
transmiss
prior
histori
diseas
pregnant
hcw
risk
due
increas
likelihood
primari
varicella
pneumonia
ard
effect
vzv
fetu
thu
pregnant
staff
care
patient
activ
vzv
howev
contact
occur
infect
control
specialist
consult
human
metapneumoviru
hmpv
worldwid
distribut
one
caus
respiratori
tract
infect
although
incid
epidemiolog
featur
remain
larg
unknown
viru
first
detect
describ
children
adult
late
wintertospr
season
variabl
one
studi
suggest
case
respiratori
diseas
come
adult
year
old
caus
approxim
respiratori
infect
howev
extent
respiratori
diseas
adult
unknown
larg
come
populationbas
studi
prospect
cohort
studi
adult
symptom
appear
includ
selflimit
cough
nasal
congest
rhinorrhea
immunocompromis
adult
lower
respiratori
tract
infect
respiratori
failur
progress
howev
appear
rare
case
describ
immunocompet
adult
signific
risk
progress
respiratori
failur
appear
transplant
diagnosi
difficult
reliabl
commerci
assay
avail
detect
larg
done
pcr
respiratori
specimen
viral
cultur
easili
obtain
well
identif
usual
done
public
health
laboratori
treatment
support
especi
sinc
case
self
limit
mortal
rate
infect
respiratori
failur
ard
unknown
death
bone
marrow
transplant
patient
report
transmiss
larg
unknown
formal
studi
exist
contact
droplet
transmiss
suspect
although
extent
spectrum
hmpv
diseas
larg
unknown
suspect
case
adult
ard
respiratori
failur
respiratori
sampl
sent
public
health
laboratori
investig
hantavirus
part
larger
genu
contain
viral
speci
genu
caus
two
sever
acut
febril
ill
hemorrhag
fever
renal
syndrom
found
old
world
hantaviru
cardiopulmonari
syndrom
hp
found
new
world
north
america
diseas
larg
report
southwest
california
case
report
canada
europ
china
chile
argentina
part
south
america
cyclic
outbreak
tend
occur
rodent
popul
increas
symptom
initi
begin
fever
chill
myalgia
prodrom
phase
lack
upper
respiratori
symptom
diseas
progress
rapidli
dri
cough
respiratori
failur
ard
shock
coagulopathi
arrhythmia
resolut
also
occur
rapidli
notabl
thrombocytopenia
immunoblastpredomin
leukocytosi
elev
hematocrit
characterist
earli
cardiopulmonari
phase
diagnosi
serolog
test
igm
earli
diseas
igg
later
diseas
public
health
laboratori
clinic
contact
rodent
endem
area
leukocytosi
elev
hematocrit
thrombocytopenia
prompt
consider
diagnosi
treatment
mainli
support
extracorpor
membran
oxygen
use
patient
ribaviron
effect
hemmorhag
fever
renal
syndrom
hp
mortal
rate
remain
approxim
transmiss
hantaviru
occur
contact
rodent
excrement
particularli
urin
viru
aerosol
mostli
occur
indoor
set
dead
rodent
rodent
urin
present
direct
live
rodent
contact
implic
transmiss
humantohuman
transmiss
document
hp
confirm
hantaviru
infect
report
public
health
offici
case
etiolog
febril
respiratori
ill
larg
unknown
admiss
icu
bacteri
pathogen
constitut
case
often
suspect
earli
base
clinic
find
gram
stain
sputum
case
may
difficult
requir
epidemiolog
diagnost
test
recent
guidelin
suggest
test
viral
pathogen
perform
patient
clinic
epidemiolog
find
suggest
viral
ill
well
place
droplet
airborn
isol
depend
suspect
pathogen
howev
mani
viral
pathogen
highli
contagi
emerg
infect
fact
may
novel
strain
often
patient
isol
test
pathogen
hospit
admiss
addit
undergo
higherrisk
aerosol
procedur
tabl
increas
likelihood
diseas
transmiss
put
hcw
patient
risk
acquir
diseas
experienc
sar
epidem
therefor
standard
approach
earli
isol
test
case
reduc
likelihood
diseas
transmiss
emerg
pathogen
within
icu
figur
outlin
approach
earli
isol
test
involv
institut
infect
control
infecti
diseas
public
health
patient
fri
respiratori
failur
admit
icu
patient
fri
respiratori
failur
immedi
isol
arriv
healthcar
system
subsequ
undergo
initi
diagnost
test
includ
pretreat
gram
stain
respiratori
cultur
urin
antigen
test
legionella
etiolog
agent
identifi
initi
screen
clinic
find
ie
gramposit
diplococci
lobar
pneumonia
radiographi
target
treatment
icu
admiss
perform
isol
patient
discontinu
point
depend
identifi
organ
howev
agent
easili
identifi
often
seen
viral
caus
fri
patient
remain
isol
diagnost
test
perform
isol
like
droplet
base
specif
epidemiolog
clue
airborn
isol
may
institut
tabl
mani
case
viral
pneumonia
icu
suspect
base
certain
atrisk
group
epidemiolog
clue
specif
clinic
find
present
test
target
pathogen
viral
cultur
isol
perform
rule
agent
well
certain
viral
pathogen
avian
influenza
sar
suspect
base
clue
hospit
infect
control
infecti
diseas
microbiolog
public
health
offici
notifi
immedi
although
bronchoscopi
gener
aerosol
increas
transmiss
risk
avoid
case
viral
isol
etiolog
becom
import
public
health
perspect
transmiss
risk
low
appropri
ppe
use
isol
viru
nasopharyng
swab
aspir
highest
earli
diseas
cours
time
patient
diseas
develop
lower
respiratori
tract
respiratori
failur
lower
respiratori
sampl
bronchoscopi
may
provid
highest
yield
addit
specif
test
sampl
sent
viral
cultur
provid
viral
isol
test
subtyp
resist
analysi
ever
indic
unless
avian
influenza
suspect
sinc
requir
biosafeti
level
laboratori
involv
institut
infect
control
infecti
diseas
specialist
microbiolog
public
health
paramount
success
contain
diseas
thu
start
earli
possibl
outlin
figur
hospitalbas
infect
control
assist
isol
hcw
protect
hospitalbas
microbiolog
laboratori
notifi
suspect
pathogen
allow
worker
protect
target
test
sampl
public
health
involv
allow
broader
viral
test
includ
addit
agent
subtyp
resist
test
agent
novel
emerg
pathogen
seen
sar
avian
influenza
earli
public
health
involv
allow
rapid
laboratori
test
epidemiolog
investig
case
definit
commun
prevent
final
public
health
also
broader
view
diseas
burden
within
region
singl
physician
see
patient
fri
ard
may
awar
multipl
case
within
region
thu
involv
public
health
allow
broader
perspect
final
aerosolgener
procedur
common
icu
patient
fri
respiratori
failur
hcw
thu
high
risk
exposur
pathogen
howev
case
transmiss
aerosolgener
procedur
cpr
bagvalv
mask
ventil
base
larg
epidemiolog
case
studi
direct
studi
lack
yet
appropri
ppe
worn
hcw
time
worn
properli
diseas
transmiss
lower
risk
thu
procedur
perform
fact
crucial
diagnosi
mani
case
fri
respiratori
failur
case
sar
avian
influenza
epidem
appear
occur
hcw
wear
appropri
ppe
appear
largest
risk
factor
transmiss
hcw
conclus
approach
patient
acut
fri
respiratori
failur
challeng
addit
manag
individu
patient
critic
ill
manag
need
includ
institut
public
health
perspect
earli
test
isol
potenti
contagi
patient
reduc
transmiss
hcw
patient
commun
small
number
viral
pathogen
like
produc
respiratori
failur
ard
target
test
often
achiev
diagnosi
earli
commun
public
health
offici
import
assist
complex
diagnosi
diseas
investig
enhanc
diagnosi
reduc
risk
transmiss
final
hcw
wear
appropri
ppe
time
reduc
risk
diseas
transmiss
highrisk
patient
